Cargando…

Metabolic Syndrome : Underlying Mechanisms and Drug Therapies /

This book provides a comprehensive overview of the development of metabolic syndrome, the underlying mechanisms and therapeutic strategies for drug development. The authors examine the context of underlying molecular pathways and integrated physiology, then expanding the discussion to diseases assoc...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Wang, Minghan, 1966-
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Hoboken, N.J. : John Wiley & Sons, ©2011.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 EBOOKCENTRAL_ocn696237308
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cnu---unuuu
008 110111s2011 njua ob 001 0 eng d
010 |z  2010019505 
040 |a N$T  |b eng  |e pn  |c N$T  |d CDX  |d YDXCP  |d E7B  |d OCLCQ  |d OCLCO  |d OCLCQ  |d NLGGC  |d MHW  |d OCLCQ  |d NLE  |d IDEBK  |d OCLCQ  |d NKT  |d DG1  |d OCLCQ  |d AZK  |d DG1  |d LOA  |d OCLCO  |d OCLCA  |d DG1  |d CHVBK  |d OCLCO  |d MOR  |d LIP  |d OCLCO  |d PIFAG  |d ZCU  |d OCLCO  |d OCLCQ  |d MERUC  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCA  |d U3W  |d OCLCA  |d OCLCQ  |d STF  |d WRM  |d COCUF  |d ICG  |d VT2  |d AU@  |d OCLCQ  |d UWO  |d OCLCO  |d OCLCA  |d WYU  |d TKN  |d OCLCQ  |d DKC  |d OCLCQ  |d OCLCO  |d UX1  |d OCLCQ  |d OCLCA  |d UKCRE  |d OCLCQ  |d OCLCO  |d VLY  |d UKAHL  |d OCLCO  |d OCLCQ  |d OCLCL 
016 7 |a 101530535  |2 DNLM 
019 |a 702844251  |a 714798766  |a 761006886  |a 811498346  |a 816616215  |a 860517764  |a 961515312  |a 962635572  |a 966258890  |a 988435409  |a 992054113  |a 1037787043  |a 1038644792  |a 1055393083  |a 1058171705  |a 1062896741  |a 1081258261  |a 1153478249  |a 1162048793  |a 1228611790  |a 1244448926  |a 1249247384 
020 |a 9780470910009  |q (electronic bk.) 
020 |a 0470910003  |q (electronic bk.) 
020 |a 9780470910016 
020 |a 0470910011 
020 |z 9780470343425 
020 |z 0470343427 
020 |a 0470922710 
020 |a 9780470922712 
020 |a 1282888986 
020 |a 9781282888982 
020 |a 9786612888984 
020 |a 6612888989 
024 8 |a 9786612888984 
029 1 |a AU@  |b 000047551138 
029 1 |a AU@  |b 000053277718 
029 1 |a CHNEW  |b 000937178 
029 1 |a CHVBK  |b 480174857 
029 1 |a DEBBG  |b BV044154743 
029 1 |a DEBSZ  |b 484998129 
029 1 |a GBVCP  |b 790033046 
029 1 |a HEBIS  |b 299817733 
029 1 |a NLGGC  |b 332403440 
029 1 |a NZ1  |b 14255833 
029 1 |a NZ1  |b 15915918 
035 |a (OCoLC)696237308  |z (OCoLC)702844251  |z (OCoLC)714798766  |z (OCoLC)761006886  |z (OCoLC)811498346  |z (OCoLC)816616215  |z (OCoLC)860517764  |z (OCoLC)961515312  |z (OCoLC)962635572  |z (OCoLC)966258890  |z (OCoLC)988435409  |z (OCoLC)992054113  |z (OCoLC)1037787043  |z (OCoLC)1038644792  |z (OCoLC)1055393083  |z (OCoLC)1058171705  |z (OCoLC)1062896741  |z (OCoLC)1081258261  |z (OCoLC)1153478249  |z (OCoLC)1162048793  |z (OCoLC)1228611790  |z (OCoLC)1244448926  |z (OCoLC)1249247384 
037 |a 288898  |b MIL 
050 4 |a RC662.4  |b .M53 2011eb 
060 4 |a 2011 D-534 
060 4 |a WK 820  |b M58695 2011 
072 7 |a MED  |x 027000  |2 bisacsh 
072 7 |a MED  |x 060000  |2 bisacsh 
072 7 |a s1me  |2 rero 
082 0 4 |a 616.3/99  |2 22 
084 |a 44.87  |2 bcl 
084 |a 44.89  |2 bcl 
049 |a UAMI 
245 0 0 |a Metabolic Syndrome :  |b Underlying Mechanisms and Drug Therapies /  |c edited by Minghan Wang. 
260 |a Hoboken, N.J. :  |b John Wiley & Sons,  |c ©2011. 
300 |a 1 online resource (xiii, 494 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references and index. 
505 0 |a Gut as an endocrine organ : the role of nutrient-sensing in energy metabolism / Minghan Wang -- Central glucose sensing and control of food intake and energy homeostasis / Lourdes Mounien and Bernard Thorens -- Abnormalities in insulin secretion in type 2 diabetes mellitus / Taly Meas and Pierre-Jean Guillausseau -- Adipokine production by adipose tissue : a novel target for treating metabolic syndrome and its sequelae / Vanessa DeClercq [and others] -- Hepatic metabolic dysfunctions in type 2 diabetes : insulin resistance and impaired glucose production and lipid synthesis / Ruojing Yang -- Energy metabolism in skeletal muscle and its link to insulin resistance / Minghan Wang -- Mechanisms and complications of metabolic syndrome / Minghan Wang -- Emerging therapeutic approaches for dyslipidemias associated with high LDL and low HDL / Margrit Schwarz and Jae B. Kim -- Mechanism of action of niacin : implications for atherosclerosis and drug discovery / Devan Marar [and others] -- Current anti-diabetic therapies and mechanisms / Minghan Wang -- GLP-1 biology, signaling mechanisms, physiology, and clinical studies / Remy Burcelin [and others] -- Dipeptidyl peptidase IV inhibitors for treatment of diabetes / C.H.S. McIntosh [and others] -- Sodium glucose co-transporter 2 inhibitors / Margaret Ryan and Serge A. Jabbour -- Fibroblast growth factor 21 as a novel metabolic regulator / Radmila Micanovic, James D. Dunbar, and Alexei Kharitonenkov -- Sirtuins as potential drug targets for metabolic diseases / Qiang Tong -- 11[beta]-hydroxysteroid dehydrogenase type 1 as a therapeutic target for type 2 diabetes / Clarence Hale and David J. St. Jean, Jr. -- Monoclonal antibodies for the treatment of type 2 diabetes : a case study with glucagon receptor blockade / Hai Yan, Wei Gu, and Murielle Veniant-Ellison -- Drug development for metabolic diseases: past, present and future / Minghan Wang. 
588 0 |a Print version record. 
520 |a This book provides a comprehensive overview of the development of metabolic syndrome, the underlying mechanisms and therapeutic strategies for drug development. The authors examine the context of underlying molecular pathways and integrated physiology, then expanding the discussion to diseases associated with metabolic syndrome. The development of drug therapies for these diseases and complications is extensively covered. The book offers a comprehensive and in-depth view of energy metabolism, metabolic tissues and pathways, molecular mechanism-based drug discovery and clinical implications. 
546 |a English. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Metabolic syndrome  |x Pathophysiology. 
650 0 |a Metabolic syndrome  |x Chemotherapy. 
650 2 |a Metabolic Syndrome  |x drug therapy 
650 2 |a Metabolic Syndrome  |x physiopathology 
650 6 |a Syndrome métabolique  |x Physiopathologie. 
650 6 |a Syndrome métabolique  |x Chimiothérapie. 
650 7 |a MEDICAL  |x Endocrinology & Metabolism.  |2 bisacsh 
650 7 |a MEDICAL  |x Nutrition.  |2 bisacsh 
650 1 7 |a Stofwisselingsziekten.  |2 gtt  |0 (NL-LeOCL)078677408 
650 1 7 |a Endocrinologie.  |2 gtt  |0 (NL-LeOCL)078497108 
655 7 |a Elektronische boeken.  |2 gtt  |0 (NL-LeOCL)303983256 
700 1 |a Wang, Minghan,  |d 1966-  |1 https://id.oclc.org/worldcat/entity/E39PCjJqh8C3m4Xb8GjwWXkWCP 
758 |i has work:  |a Metabolic syndrome (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCFY3VTQggXwtKPhG8rg4mb  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |t Metabolic syndrome.  |d Hoboken, N.J. : John Wiley & Sons, ©2011  |z 9780470343425  |w (DLC) 2010019505  |w (OCoLC)614271402 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=698739  |z Texto completo 
938 |a Coutts Information Services  |b COUT  |n 16423829  |c 83.50 GBP 
938 |a ebrary  |b EBRY  |n ebr10441458 
938 |a EBSCOhost  |b EBSC  |n 346516 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n 288898 
938 |a YBP Library Services  |b YANK  |n 3350533 
938 |a YBP Library Services  |b YANK  |n 12667894 
938 |a YBP Library Services  |b YANK  |n 3536528 
938 |a Askews and Holts Library Services  |b ASKH  |n AH13355483 
994 |a 92  |b IZTAP